(E)-tert-butyldimethyl((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl)oxy)silane

Catalog No. :
ACLSDG825
CAS No. :
277331-67-6
Molecular Formula :
C17H35BO3Si
Molecular Weight :
326.24

IUPAC Name:(E)-tert-butyldimethyl((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl)oxy)silane

(E)-tert-butyldimethyl((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl)oxy)silane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$242.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(E)-tert-butyldimethyl((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl)oxy)silane
IUPAC Name(E)-tert-butyldimethyl((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl)oxy)silane
MDL No.0
Molecular FormulaC17H35BO3Si
Molecular Weight326.24
SMILESCC(C)(C)[Si](C)(C)OCCC/C=C/B1OC(C)(C(C)(O1)C)C
InChI KeyLRUHQAVNAZLVKC-ACCUITESSA-N
Synonym1,3,2-Dioxaborolane, 2-[(1E)-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-penten-1-yl]-4,4,5,5-tetramethyl-;(E)-5-[(tert-Butyldimethylsilyl)oxy]pent-1-ene-1-boronic Acid Pinacol Ester;(E)-tert-Butyldimethyl((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-en-1-yl)oxy)silane
CAS No.277331-67-6

Synthetic Route by SureRoute

1. ACLSDG825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWLEF012 route compound structure diagram
    ACWLEF01276-09-5 In Stock
  4. Then
  5. ACLSDG825 route product structure diagram
    ACLSDG825277331-67-6
Inquiry

2. ACLSDG825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLSDG825 route product structure diagram
    ACLSDG825277331-67-6
Inquiry

Comments (0)